Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARCT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ARCT
Arcturus Therapeutics Holdings Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARCT
Arcturus Therapeutics Holdings Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ARCT, solid
LLY, dashed
ARCT
Arcturus Therapeutics Holdings Inc.
Change
10.39
▲
+8.95%
Mkt cap
$271.2M
Revenue
$3M
Q2 FY26
Revenue
$82M
FY25
LLY
ELI Lilly & Co
Change
1,429.57
▲
+1.43%
Regular session
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 4 '26
ARCT
Arcturus Therapeutics Holdings Inc.
vs
LLY
ELI Lilly & Co
10.39
▲
+8.95%
Price
1,429.57
▲
+1.43%
$271.2M
Mkt cap
$1.3T
Q2 FY26
$3M
Revenue
$24.4B
Q3 FY26
FY25
$82M
Revenue
$65.2B
FY25
Change
Change
ARCT
10.39
▲
+8.95%
vs
LLY
1,429.57
▲
+1.43%
Regular session
Nov 4 '26